NCT02292550 2020-12-17Study of Safety and Efficacy of LEE011 and Ceritinib in Patients With ALK-positive Non-small Cell Lung Cancer.NovartisPhase 1 Completed27 enrolled
NCT01742286 2020-06-09Phase I Study of LDK378 in Pediatric, Malignancies With a Genetic Alteration in Anaplastic Lymphoma Kinase (ALK)NovartisPhase 1 Completed83 enrolled 30 charts